Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment

• Egile Nagusiak: Okumura LM (Egilea), Antunes VD (Egilea), Aguiar KS (Egilea), Farias T (Egilea), Andrzejevski VM (Egilea), Funke VM (Egilea)
• Formatua: Liburua
• Argitaratua: Centro de Investigaciones y Publicaciones Farmaceuticas, 2015-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objective: To assess the role of social risk factors on adherence to tyrosine kinase inhibitors (TKI) therapy in chronic myeloid leukemia (CML) patients. Methods: This is a retrospective study and eligible patients were adults with CML on TKI treatment. Cases of no adherence to treatment were confir...